Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Sliven

85 clinical trials in Sliven, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Sliven at a glance
85
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

85 trials in Sliven

Open in trial search
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:BulgariaBulgaria
  • Participants:0–17 years
  • Substances:Desloratadine
  • Sponsor:Allergy Therapeutics (UK) Limited
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Clazakizumab
  • Sponsor:CSL Behring LLC
Countries:BulgariaBulgaria
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years
  • Substances:Vafidemstat
  • Sponsor:Oryzon Genomics S.A.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Sliven

What the registry says about research in the country

01 Respiratory Medicine

Clinical trials focusing on respiratory conditions including innovative treatments for asthma management and COPD. Research includes evaluation of new inhalation therapies and combination treatments.

  • Moderate to Severe Asthma
  • Chronic Obstructive Pulmonary Disease
  • Inhaler Technology Development

Studies aim to improve symptom control and quality of life for patients with chronic respiratory conditions.

02 Cardiovascular Research

Extensive research into cardiovascular diseases and related conditions, including studies on heart failure, atherosclerosis, and hypertension management.

  • Atherosclerotic Cardiovascular Disease
  • Heart Failure Management
  • Hypertriglyceridemia Treatment

Focus on preventing major cardiovascular events and improving patient outcomes through innovative therapies.

03 Immunology and Inflammation

Studies examining new treatments for autoimmune disorders and inflammatory conditions, including breakthrough therapies for various forms of arthritis.

  • Psoriatic Arthritis
  • Sjögren's Disease
  • Ulcerative Colitis

Research aims to reduce inflammation and improve disease management in chronic conditions.

04 Infectious Diseases

Research focusing on viral infections and their treatment, including studies of influenza vaccines and therapeutic approaches.

  • Influenza Prevention
  • Hepatitis Delta Treatment
  • Urinary Tract Infections

Emphasis on developing effective treatments and preventive measures for various infectious conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).